Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

The treatment might help COVID-19 related hair loss, but more research is needed.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

COVID-19 is linked to temporary hair loss, especially in women.

COVID-19 infection is highly related to increased hair loss, especially in women.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.

Testosterone may influence COVID-19 severity and outcomes.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

Testosterone's effects on COVID-19 are unclear and need more research.

Some drugs may help treat both COVID-19 and radiation injury.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Nursing staff's mental health was affected during the COVID-19 pandemic.

The document concludes that Passiflora incarnata could help with anxiety, telemedicine might improve heart failure care, screen time for kids has increased, pregnant teens in Brazil are mostly okay with their body image, rare tuberculosis infection can occur after knee surgery, older and severely ill people are more likely to have long COVID-19 symptoms, HPLC might diagnose more diabetes cases, and psychiatrists should be involved in pain management.